Time to calcitonin normalization after surgery for node-negative and node-positive medullary thyroid cancer

Area of Science:

• Endocrinology
• Oncology
• Surgical Oncology

Background:

• Optimal timing for postoperative serum calcitonin measurement in medullary thyroid cancer (MTC) remains unclear.
• The influence of preoperative calcitonin levels and nodal status on this timing requires further investigation.

Purpose of the Study:

• To determine the optimal timing for postoperative serum calcitonin measurement in MTC patients.
• To evaluate the impact of preoperative calcitonin levels and nodal status on the time to calcitonin normalization after surgery.

Main Methods:

• Kaplan-Meier analysis was used to assess the time to calcitonin normalization in a cohort of untreated MTC patients.
• Analyses were stratified by preoperative calcitonin levels, nodal status, and the number of nodal metastases.

Main Results:

• Postoperative calcitonin normalization was significantly influenced by both preoperative calcitonin levels and nodal status.
• Patients with higher preoperative calcitonin levels (>500 pg/ml) and more extensive nodal metastases (>10) experienced prolonged normalization times, sometimes extending beyond a fortnight.
• While normalization curves were similar for node-negative MTC, they diverged significantly in node-positive cases with increasing nodal burden.

Conclusions:

• Postoperative calcitonin normalization in MTC is dependent on preoperative calcitonin levels and nodal status.
• Higher preoperative calcitonin levels and greater nodal involvement necessitate longer observation periods for calcitonin normalization.
• These findings can inform the timing of postoperative monitoring in MTC patients.